GW PHARMACEUTICALS PLC Operating Cash Flow
GW PHARMACEUTICALS PLC reported Operating Cash Flow of -$11.72 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-05-03
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$11.72M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was $5.93M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was $1.03M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$15.74M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for fiscal 2020 was -$27.39M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for fiscal 2019 was -$123.47M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for fiscal 2018 was -$231.87M.
- GW PHARMACEUTICALS PLC net cash provided by (used in) operating activities for fiscal 2017 was -$148.97M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$11.72M 10-Q · filed 2021-05-03 | -$5.79M derived: sum of 2 quarters · filed 2021-05-03 | -$4.77M derived: sum of 3 quarters · filed 2021-05-03 | -$20.51M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $6.96M derived: sum of 2 quarters · filed 2021-02-26 | -$8.79M derived: sum of 3 quarters · filed 2021-02-26 | -$27.39M 10-K · filed 2021-02-26 |
| 2020-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$14.72M derived: sum of 2 quarters · filed 2020-11-05 | -$33.31M 10-Q · filed 2020-11-05 | -$49.26M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | -$15.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$34.34M 10-Q · filed 2020-08-07 | -$50.29M derived: sum of 3 quarters · filed 2021-05-03 | -$67.95M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | -$18.60M 10-Q · filed 2021-05-03 | -$34.55M derived: sum of 2 quarters · filed 2021-05-03 | -$52.21M derived: sum of 3 quarters · filed 2021-05-03 | -$83.69M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$15.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$33.61M derived: sum of 2 quarters · filed 2021-02-26 | -$65.09M derived: sum of 3 quarters · filed 2021-02-26 | -$123.47M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$17.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$49.14M derived: sum of 2 quarters · filed 2020-11-05 | -$107.52M 10-Q · filed 2020-11-05 | -$181.98M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$31.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$89.86M 10-Q · filed 2020-08-07 | -$164.32M derived: sum of 3 quarters · filed 2021-02-26 | -$246.32M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$58.38M 10-Q · filed 2020-05-11 | -$132.84M derived: sum of 2 quarters · filed 2021-02-26 | -$214.84M derived: sum of 3 quarters · filed 2021-02-26 | -$247.75M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$74.46M 10-K · filed 2021-02-26 | -$156.46M derived: sum of 2 quarters · filed 2021-02-26 | -$189.37M derived: sum of 3 quarters · filed 2021-02-26 | -$254.77M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | -$82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$114.91M derived: sum of 2 quarters · filed 2019-11-06 | -$180.31M 10-Q · filed 2019-11-06 | -$231.87M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$32.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$98.31M 10-Q · filed 2019-08-07 | -$149.87M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | -$65.40M 10-Q · filed 2019-05-08 | -$116.96M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | -$51.56M 10-K · filed 2021-02-26 | |||
| 2017-09-30 | -$148.97M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | -$119.93M 10-KT · filed 2019-02-28 |